FDA issues warning to local doctor for breaking protocol on drug trial
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Health Care Businesses
Articles
Blame game over drug prices escalates with new ad campaign
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
Lilly among firms pulling ads from ‘O’Reilly Factor’
A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.
Local Roche units sue pharmacies over alleged test-strip scheme
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
Lilly CEO Ricks stands to make about $12M in first year at helm
Dave Ricks joined Lilly in 1996 and most recently served as president of Lilly Bio-Medicines. He took over as president and CEO on Jan. 1.
St. Vincent planning $13.6M education center on hotel site
The hospital system plans to tear down a two-story hotel near its Indianapolis flagship campus and build a training facility for simulating situations in acute care.
Pharma stocks slide after new tweet from Trump on drug prices
Share of Eli Lilly and Co. and numerous other drug industry stocks fell Tuesday morning after the president sent a tweet promising to lower medicine costs for American people.
Drug companies willing to spend big in pursuit of Alzheimer’s cure
Alzheimer’s disease is rewriting the rules of drug discovery, with companies like Eli Lilly and others abandoning caution to keep pursuing an elusive hypothesis because the potential payoff is so great.
As pricing criticism mounts, Lilly, other drugmakers roll out pay for performance
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Merck stops Alzheimer’s study after ‘no chance’ of benefit
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
Local health care facility with 87 employees shutting down
The closure of an Indianapolis residential care facility is expected to result in the loss of 87 jobs, but some of the workers might be able to land employment at the same company.
Eli Lilly aims to cut 200 R&D jobs
The Indianapolis-based drugmaker has offered many of its research and development employees a compensation package if they leave the company.
Lilly CEO encouraged by Trump meeting, concerned about Obamacare
Eli Lilly and Co. CEO Dave Ricks said he was encouraged by President Donald Trump’s understanding of the complexities of drug development, yet he’s concerned about risks the industry may face in a fresh overhaul of the U.S. health-care system.
Trump spoils pharma chiefs with no more bad news on drug pricing
For drugmakers, including Indianapolis-based Eli Lilly and Co., a meeting Tuesday with President Donald Trump was a dose of happy pills.
UPDATE: Trump tells drugmakers, including Lilly, their prices are ‘astronomical’
President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
Eli Lilly earnings rise sharply but narrowly miss analysts’ expectations
The Indianapolis-based drugmaker got a revenue boost from a host of new medications but also saw sales fall sharply for some older products.
Get ready for a smoking-hot debate over cigarette taxes
Indiana now has one of the lowest cigarette taxes in the nation. It also has one of the highest smoking rates. Some groups want to decrease the latter in part by raising the former.
Former COO of health firm claims discrimination in firing
A former executive at an Indianapolis-based chain of health clinics says he was fired because of his age, race and national origin, and in retaliation because he stood up for one of his female managers.
Lilly shares rise after Alimta cancer drug patent upheld on appeal
Teva Pharmaceuticals Industries Ltd.’s proposed generic version infringes a patent on the multi-billion-dollar patent, the U.S. Court of Appeals for the Federal Circuit ruled.
Lilly exec Azar departs as new CEO makes organizational changes
Alex Azar, president of Lilly USA LLC since 2012, is leaving the company just as his unit is about to lose a huge swath of sales personnel. The drugmaker announced a series of changes Thursday under new CEO David Ricks.